Navigation Links
Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth
Date:4/29/2008

to Cynosure's historical performance and our competitors' operating results. Cynosure believes that these non-GAAP measures are useful to investors in allowing for greater transparency with respect to supplemental information used by management in its financial and operational decision making.

Conference Call

Cynosure will host a conference call for investors today at 9:00 a.m. ET. On the call, Michael Davin and Timothy Baker, the company's Executive Vice President and Chief Financial Officer, will discuss the first quarter 2008 financial results, provide a business update and discuss the company's growth strategy.

Those who wish to listen to the conference call webcast should visit the "Investor Relations" section of the company's website at http://www.cynosure.com. The live call also can be accessed by dialing (877) 407-5790 or (201) 689-8328. If you are unable to listen to the live call, the webcast will be archived on the company's website.

About Cynosure, Inc.

Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular lesions, rejuvenate skin through the treatment of shallow vascular and pigmented lesions, laser lipolysis and temporarily reduce the appearance of cellulite. Cynosure's products include a broad range of laser and other light-based energy sources, including Alexandrite, pulsed dye, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991.

For corporate or product information, contact Cynosure at 800-886-2966, or visit http://www.cynosure.com.

Safe Harbor

Any statements in this press release about future expectations, plans and prospects for Cynosure, Inc., including statements about the company's expectations and futur
'/>"/>

SOURCE Cynosure, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Cynosure to Present at the Leerink Swann & Company/MEDACorp Aesthetics Roundtable Conference
2. Cynosure to Announce Fourth-Quarter and Full Year 2007 Financial Results on February 12
3. Cynosure Reports Record Revenues and Net Income for the Fourth Quarter of 2007
4. Cynosure Announces Upcoming Investor Presentations at Cowen and Citi Investor Conferences
5. Cynosure Introduces Smartlipo MPX(TM) Dual Wavelength Workstation for LaserBodySculpting(SM)
6. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
7. QMed, Inc. Reports July Medicare SNP Enrollments
8. Phlo Affiliate Reports Expanded Coverage to Oregon Border
9. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
10. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
11. Carrington Reports Second Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2009)... China Biologic,Products, Inc. (Nasdaq: CBPO ) ("China ... biopharmaceutical companies in China, today announced,that the Company,s ... at the,NASDAQ MarketSite in New York City at ... China Biologic,s common stock ... 2, 2009, under the ticker symbol "CBPO." , ...
(Date:12/10/2009)... BEIJING, Dec. 10 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, ... "Company") a growing developer and,producer of prescription ... in the People,s Republic of China ("PRC"), ... Fang, a controlled operating entity of Lotus,appointed ... of the Company,s,Over-the-Counter Drug division ("OTC Division"). ...
(Date:12/10/2009)... today that it has entered into a multi-year, sole-source supply ... for the use of Martek’s products in Fonterra’s infant formulas ... , ... Columbia, MD (Vocus) December ... announced today that it has entered into a multi-year, sole-source ...
(Date:12/10/2009)... Optimized Antibodies Produces First Candidates Which Selectively ... ON, Dec. 10 /PRNewswire-FirstCall/ - YM BioSciences ... first results of a collaborative program between ... of Canada,s Biotechnology Research Institute (NRC-BRI). ... designed to generate novel antibodies that target ...
Breaking Biology Technology:China Biologic Products to Ring NASDAQ Opening Bell 2China Biologic Products to Ring NASDAQ Opening Bell 3Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 2Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 3Martek Signs Sole-Source Supply Agreement with Fonterra 2Martek Signs Sole-Source Supply Agreement with Fonterra 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 2YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 4YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 5
... Inc. (OTC,Bulletin Board: SCIE) announced today that Jim Dorst ... and Chief Financial Officer., Jim Hitchin the Company,s ... of,experience in public medical device, manufacturing and software firms. ... ago. With a graduate,degree in accounting, he is well ...
... New class of ApoA-I/HDL drugs to reverse atherosclerosis enters the clinic ... ... Resverlogix Corp.,("Resverlogix") (TSX:RVX) announced today that it has received approval by,the ... clinical,trial of oral RVX-208 in the USA. RVX-208 is a novel ...
... Nash Corporation,(Nasdaq: KNSY ) is scheduled to participate ... & Tissue" at the 2007 RBC Capital Markets,Healthcare Conference., ... in the panel,discussion on Thursday, December 13th at 8:00 ... in New York. The conference is by invitation only,however ...
Other Biology Technology:Jim Dorst Joins SpectraScience as CFO 2FDA Grants Resverlogix Approval to Commence a Phase 1 Clinical Trial for RVX-208 2FDA Grants Resverlogix Approval to Commence a Phase 1 Clinical Trial for RVX-208 3
(Date:12/13/2009)... that may help to engineer plants that take advantage ... The finding could help to engineer crops that take ... the carbon dioxide they need for photosynthesis through microscopic ... each molecule of the gas gained, they lose hundreds ... can tighten to save water when CO 2 ...
(Date:12/13/2009)... Yale University researchers has used nanosensors to measure ... time. Their findings, which appear December 13 in ... , could dramatically simplify the way physicians test ... , The teamled by Mark Reed, Yale,s ... and Tarek Fahmy, an associate professor of biomedical ...
(Date:12/13/2009)... 2009Researchers at The Scripps Research Institute have solved ... from an ancient family of enzymes can have ... addition to providing guidance for understanding other molecules ... underpinning for the protein,s possible use for combating ... research was published in the December 13, 2009 ...
Breaking Biology News(10 mins):Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 3Scientists use nanosensors for first time to measure cancer biomarkers in blood 2Scripps Research scientists crack mystery of protein's dual function 2Scripps Research scientists crack mystery of protein's dual function 3Senior doctors launch global movement to tackle climate change 62112 1Senior doctors launch global movement to tackle climate change 62112 2Feeding the clock 10896 1Feeding the clock 10896 2Feeding the clock 10896 3Salt Really Does Boost Health Risks 62109 1
... human knees is even more common in dogs. Each ... cruciate ligament (CCL) deficiency, which is comparable to the ... method of treatment by many veterinary surgeons involves cutting ... these dogs. Now, a new minimally invasive technique with ...
... Investigator, has been named a Pew Scholar in Biomedical ... an award of $240,000 over four years. , ... on the basis of performance during education and training ... relevant to human health. The Pew Charitable Trusts seek ...
... in German . , Because of its ... tetrachloride, CCl4) can no longer be used or produced in ... other chlorinated hydrocarbons, such as chloroform (trichloromethane, CHCl3), also produce ... get rid of this unwanted substance? A team headed by ...
Other Biology News:Technique used in human ankle injuries modified to treat dogs' knees 2Julia Zeitlinger named Pew Scholar 2Fair trade 2
AedestaTM Animal Organ/Tissue Perfusion Soln....
Reusble. Uses in conjunction with the Apoptotic Cell Isolation Kit....
EGTA, 10 g. Ethylene glycol-O,O-bis-[2-amino-ethyl]-N,N,N,N,-tetraacetic acid.Assay: > 99.0%. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
...
Biology Products: